Your browser doesn't support javascript.
SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.
Afshar, Zeinab Mohseni; Barary, Mohammad; Babazadeh, Arefeh; Hosseinzadeh, Rezvan; Alijanpour, Amirmasoud; Miri, Seyed Rouhollah; Sio, Terence T; Sullman, Mark J M; Carson-Chahhoud, Kristin; Langer, Florian; Ebrahimpour, Soheil.
  • Afshar ZM; Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Barary M; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
  • Babazadeh A; Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
  • Hosseinzadeh R; Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
  • Alijanpour A; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
  • Miri SR; Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Sio TT; Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran, Iran.
  • Sullman MJM; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Carson-Chahhoud K; Department of Social Sciences, University of Nicosia, Nicosia, Cyprus.
  • Langer F; Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.
  • Ebrahimpour S; Australian Centre for Precision Health, University of South Australia, Adelaide, Australia.
Rev Med Virol ; 32(4): e2327, 2022 07.
Article in English | MEDLINE | ID: covidwho-1669636
ABSTRACT
Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / COVID-19 Vaccines / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rev Med Virol Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Rmv.2327

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / COVID-19 Vaccines / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rev Med Virol Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Rmv.2327